Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2010 1
2011 1
2013 1
2014 1
2015 2
2016 2
2017 5
2018 4
2019 8
2020 4
2021 9
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Todisco E, Papayannidis C, Fracchiolla N, Petracci E, Zingaretti C, Vetro C, Martelli MP, Zappasodi P, Di Renzo N, Gallo S, Audisio E, Griguolo D, Cerchione C, Selleri C, Mattei D, Bernardi M, Fumagalli M, Rizzuto G, Facchini L, Basilico CM, Manfra I, Borlenghi E, Cairoli R, Salutari P, Gottardi M, Molteni A, Martini V, Lunghi M, Fianchi L, Cilloni D, Lanza F, Abruzzese E, Cascavilla N, Rivellini F, Ferrara F, Maurillo L, Nanni J, Romano A, Cardinali V, Gigli F, Roncoroni E, Federico V, Marconi G, Volpi R, Sciumè M, Tarella C, Rossi G, Martinelli G; AVALON Cooperative Group. Todisco E, et al. Among authors: petracci e. Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24. Cancer. 2023. PMID: 36692409 Free article.
Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
Chiorino G, Petracci E, Sehovic E, Gregnanin I, Camussi E, Mello-Grand M, Ostano P, Riggi E, Vergini V, Russo A, Berrino E, Ortale A, Garena F, Venesio T, Gallo F, Favettini E, Frigerio A, Matullo G, Segnan N, Giordano L. Chiorino G, et al. Among authors: petracci e. Sci Rep. 2023 Jul 25;13(1):12040. doi: 10.1038/s41598-023-38886-0. Sci Rep. 2023. PMID: 37491482 Free PMC article.
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Canale M, Petracci E, Cravero P, Mariotti M, Minuti G, Metro G, Ludovini V, Baglivo S, Puccetti M, Dubini A, Martinelli G, Delmonte A, Crinò L, Ulivi P. Canale M, et al. Among authors: petracci e. Transl Oncol. 2022 Sep;23:101471. doi: 10.1016/j.tranon.2022.101471. Epub 2022 Jun 29. Transl Oncol. 2022. PMID: 35779323 Free PMC article.
Fall predictors in hospitalized patients living with cancer: a case-control study.
Zeneli A, Montalti S, Masciangelo I, Manieri G, Golinucci M, Nanni O, Montella MT, Martinelli G, Petracci E. Zeneli A, et al. Among authors: petracci e. Support Care Cancer. 2022 Oct;30(10):7835-7843. doi: 10.1007/s00520-022-07208-x. Epub 2022 Jun 16. Support Care Cancer. 2022. PMID: 35705752
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis.
Solimando AG, Susca N, Argentiero A, Brunetti O, Leone P, De Re V, Fasano R, Krebs M, Petracci E, Azzali I, Nanni O, Silvestris N, Vacca A, Racanelli V. Solimando AG, et al. Among authors: petracci e. Clin Exp Med. 2022 Feb;22(1):65-74. doi: 10.1007/s10238-021-00727-7. Epub 2021 Jun 19. Clin Exp Med. 2022. PMID: 34146196 Free PMC article.
50 results